Calidi Biotherapeutics Inc. Showcases Breakthrough in Cancer Treatment with Genetic Medicine Platform
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has recently gained attention for its precision genetic medicine platform, as detailed in a NetworkNewsWire editorial. This platform is designed to target both primary...